A multicenter study of supportive‐expressive group therapy for women with BRCA1/BRCA2 mutations

Abstract

The feasibility of a supportive-expressive group for BRCA1/BRCA2 mutation carriers was demonstrated. Findings from the study are consistent with an effective intervention. However, further research is required using a randomized controlled study design.